Epizyme's ROA from the second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Epizyme's ROA in the second quarter of 2022?
Epizyme Inc. recorded a cumulative net loss of $-208 million during 12 months ending in the second quarter of 2022, resulting in a negative return on assets (ROA) of -73.79%.

However, within the Healthcare sector 922 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2022 from 5198 to 5221.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter
Y / Y Total Assets Change	-27 %	-24.68 %	-40.73 %	-13.79 %	-17.05 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-208	-236	-251	-267	-257
Return On Assets (TTM)	-73.79 %	-77.64 %	-76.42 %	-71.11 %	-66.3 %
EPZM's Total Ranking	# 5221	# 5198	# 5541	# 4559	# 4558
Total Assets (TTM) in million	248	295	270	313	339
Seq. Total Assets Change	-15.99 %	9.01 %	-13.66 %	-7.68 %	-13.32 %
Seq. Net Income Change	-	-	-	-	-

EPZM's 5 Years Annual ROA >> Back to EPZM Management Effectiveness >> Compare EPZM ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 436
Sector	# 923
Overall	# 5102

Return On Assets Statistics
High	Average	Low
85.66 %	-37.37 %	-73.52 %
(Dec 31 2013)		(Mar 31 2022)

Financial Statements
Epizyme's Assets	$ 248 million	EPZM's Balance sheet
Epizyme's Income	$ -36 million	Quarterly EPZM's Income Statement
EPZM's Income by Division		See EPZM's Income by Division

Annual Return On Assets	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017
Y / Y Total Assets Change	-40.73 %	7.51 %	54.05 %	-4.79 %	14.62 %
Total Assets in million	270	456	424	276	289
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-251	-232	-170	-124	-134
Annual Return On Assets	-92.86 %	-50.78 %	-40.13 %	-44.87 %	-46.42 %

EPZM's 5 Years Annual ROA >> Back to EPZM Management Effectiveness >> Compare EPZM ROA to its Competitors

More Return On Assets Ratios
EPZM's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EPZM's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EPZM's Competitors
Subscribers only: Roa for Epizyme's Suppliers
Subscribers only: Return On Assets for EPZM's Customers

You may also want to know
EPZM's Roi	EPZM's Inventory Turnover Ratio	EPZM's Growth Rates	EPZM's Dividend Comparisons
	EPZM's Profitability Ratios	EPZM's Asset Turnover Ratio	EPZM's Dividend Growth
EPZM's Roe	EPZM's Valuation Ratios	EPZM's Financial Strength Ratios	EPZM's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2022, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.